7:22 PM
 | 
Mar 01, 2007
 |  BC Extra  |  Financial News

Neuropharm prices IPO

Neurology company Neuropharm (LSE:NPH) raised L20 million ($39.3 million) in an IPO on the LSE's AIM through the sale of 15.7 million shares at 127p, which values...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >